BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35284003)

  • 1. The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry.
    Krittayaphong R; Winijkul A; Methavigul K; Sairat P; Investigators COOLF
    Cardiovasc Ther; 2022; 2022():5797257. PubMed ID: 35284003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
    Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
    Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
    JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.
    Ahn HJ; Lee SR; Choi J; Lee KY; Kwon S; Choi EK; Oh S; Lip GYH
    Europace; 2024 Feb; 26(2):. PubMed ID: 38290433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population, Data from the COOL-AF Thailand registry.
    Chantrarat T; Krittayaphong R
    Int J Cardiol; 2021 Jan; 323():90-99. PubMed ID: 32828960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke - ANAFIE Registry.
    Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K;
    Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.
    Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A;
    BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
    Krittayaphong R; Winijkul A; Kunjara-Na-Ayudhya R; Apiyasawat S; Siriwattana K; Kanjanarutjawiwat W; Dutsadeevettakul S; Lip GYH;
    Stroke; 2020 Jun; 51(6):1772-1780. PubMed ID: 32390554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation.
    McGrath ER; Kapral MK; Fang J; Eikelboom JW; Conghaile Aó; Canavan M; O'Donnell MJ;
    Stroke; 2014 Dec; 45(12):3637-42. PubMed ID: 25378422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry.
    Krittayaphong R; Boonyapiphat T; Wongvipaporn C; Sairat P;
    Clin Interv Aging; 2021; 16():707-719. PubMed ID: 33953549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry.
    Krittayaphong R; Winijkul A; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Kaewcomdee P; Yindeengam A;
    J Geriatr Cardiol; 2020 Apr; 17(4):184-192. PubMed ID: 32362916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
    Mazurek M; Halperin JL; Huisman MV; Diener HC; Dubner SJ; Ma CS; Rothman KJ; Healey JS; Teutsch C; Paquette M; França LR; Lu S; Bartels DB; Lip GYH
    Europace; 2020 Jan; 22(1):47-57. PubMed ID: 31651951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry.
    Cools F; Johnson D; Camm AJ; Bassand JP; Verheugt FWA; Yang S; Tsiatis A; Fitzmaurice DA; Goldhaber SZ; Kayani G; Goto S; Haas S; Misselwitz F; Turpie AGG; Fox KAA; Pieper KS; Kakkar AK;
    J Thromb Haemost; 2021 Sep; 19(9):2322-2334. PubMed ID: 34060704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
    Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.